Sector Gamma AS’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.73M | Sell |
122,348
-15,000
| -11% | -$825K | 2.2% | 18 |
|
|
2025
Q1 | $9.71M | Sell |
137,348
-80,000
| -37% | -$5.66M | 3.11% | 13 |
|
|
2024
Q4 | $14.3M | Buy |
217,348
+27,000
| +14% | +$1.77M | 4.91% | 7 |
|
|
2024
Q3 | $13.4M | Buy |
190,348
+127,000
| +200% | +$8.93M | 4.06% | 10 |
|
|
2024
Q2 | $5.22M | Sell |
63,348
-18,068
| -22% | -$1.49M | 1.95% | 21 |
|
|
2024
Q1 | $7.11M | Sell |
81,416
-4,831
| -6% | -$422K | 2% | 19 |
|
|
2023
Q4 | $8.32M | Sell |
86,247
-9,801
| -10% | -$945K | 2.02% | 19 |
|
|
2023
Q3 | $8.5M | Sell |
96,048
-66,620
| -41% | -$5.89M | 2.17% | 18 |
|
|
2023
Q2 | $14.1M | Buy |
162,668
+6,318
| +4% | +$548K | 3.15% | 13 |
|
|
2023
Q1 | $15.2M | Buy |
156,350
+1,341
| +0.9% | +$130K | 3.69% | 10 |
|
|
2022
Q4 | $16M | Buy |
155,009
+45,405
| +41% | +$4.7M | 3.67% | 11 |
|
|
2022
Q3 | $9.29M | Buy |
109,604
+4,345
| +4% | +$368K | 2.39% | 16 |
|
|
2022
Q2 | $8.72M | Buy |
105,259
+25,500
| +32% | +$2.11M | 1.95% | 20 |
|
|
2022
Q1 | $6.15M | Sell |
79,759
-33,789
| -30% | -$2.6M | 1.34% | 27 |
|
|
2021
Q4 | $10M | Buy |
+113,548
| New | +$10M | 2.36% | 18 |
|
|
2021
Q3 | – | Sell |
-68,964
| Closed | -$5.75M | – | 32 |
|
|
2021
Q2 | $5.75M | Sell |
68,964
-22,750
| -25% | -$1.9M | 1.02% | 29 |
|
|
2021
Q1 | $6.93M | Buy |
+91,714
| New | +$6.93M | 1.27% | 26 |
|
|
2020
Q3 | – | Sell |
-108,482
| Closed | -$13.4M | – | 29 |
|
|
2020
Q2 | $13.4M | Sell |
108,482
-31,100
| -22% | -$3.84M | 2.76% | 17 |
|
|
2020
Q1 | $11.8M | Buy |
139,582
+64,679
| +86% | +$5.47M | 2.51% | 18 |
|
|
2019
Q4 | $6.33M | Buy |
+74,903
| New | +$6.33M | 1.01% | 29 |
|